BeStock  
Stocks › Biotechnology › ABUS

Arbutus Biopharma ABUS

US equityMarket cap rank #3471Biotechnology
$4.02 −$0.05 (-1.23%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $3.98 -1.00%
Open$4.01
Prev close$4.07
Day range$3.97 – $4.09
Volume2.99M
Market cap$616.24M
P/E (TTM)3.6
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings3.7x
CheapRich

Near the top of its 5-year range · 90th percentile, 5-year average -6.6x

#153 of 2991 stocks by PE (1 = cheapest)

Price / book7.3x
CheapRich

Near the top of its 5-year range · 80th percentile, 5-year average 3.9x

#4748 of 5329 stocks by PB (1 = cheapest)

Price / sales3.5x
CheapRich

Near the bottom of its 5-year range · 0th percentile, 5-year average 40.0x

#3409 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-29x-16x-4x9xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$3.53
Price vs. fair value+13.9%Trading above the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 7.32 – 3.91 80% (pricier than usual) #4748 of 5329 (1 = cheapest)
PE 3.65 -38.40 -6.63 90% (pricier than usual) #153 of 2991 (1 = cheapest)
PS 3.45 161.25 40.05 0% (cheaper than usual) #3409 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on ABUS.

Sign in to join the discussion.

Scroll to Top